Envoy Medical, Inc.
NASDAQ Capital MarketTotal Valuation
Envoy Medical, Inc. carries a market capitalization of 821,600.00, placing it among publicly traded companies globally. Its enterprise value stands at -15.02M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 821,600.00 |
| Enterprise Value | -15.02M |
Share Statistics
Envoy Medical, Inc. currently has 77.19M shares outstanding.
| Shares Outstanding | 77.19M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | 1.04 |
| P/TBV Ratio | 1.04 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Financial Position
Envoy Medical, Inc. maintains a current ratio of 1.73, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 21.93, indicating elevated leverage, while an interest coverage ratio of -49.51 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.73 |
| Quick Ratio | 1.56 |
| Debt / Equity | 21.93 |
| Debt / EBITDA | -0.03 |
| Interest Coverage | -49.51 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -138.27 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 0.63 |
Stock Price Statistics
Envoy Medical, Inc.'s stock has gained approximately 8.83941% over the past 52 weeks. The 50-day moving average sits at 0.04, while the 200-day moving average is 0.05.
| Beta (5Y) | N/A |
| 52-Week Price Change | 8.83941% |
| 50-Day Moving Average | 0.04 |
| 200-Day Moving Average | 0.05 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -23.32M, while operating income came in at -23.62M.
| Revenue | 207,000.00 |
| Gross Profit | -798,000.00 |
| Operating Income | -23.62M |
| Pretax Income | -23.40M |
| Net Income | -23.40M |
| EBITDA | -23.32M |
| EBIT | -23.62M |
| Earnings Per Share (EPS) | N/A |
Balance Sheet
Envoy Medical, Inc. holds 19.68M in cash and equivalents against 810,000.00 in total debt, resulting in a net debt position of -19.68M. Total book value stands at 3.69M, with working capital of 9.28M providing operational flexibility.
| Cash & Cash Equivalents | 19.68M |
| Total Debt | 810,000.00 |
| Net Debt | -19.68M |
| Equity (Book Value) | 3.69M |
| Book Value Per Share | 0.05 |
| Working Capital | 9.28M |
Cash Flow
Envoy Medical, Inc. produced -21.53M in operating cash flow over the past twelve months.
| Operating Cash Flow | -21.53M |
| Capital Expenditures | -178,000.00 |
| Free Cash Flow | -21.71M |
| FCF Per Share | N/A |
Margins
Envoy Medical, Inc. operates with a gross margin of -385.51, reflecting its pricing power and cost economics. The operating margin of -11,411.11 and net profit margin of -11,304.83 provide insight into operational efficiency.
| Gross Margin | -385.51 |
| Operating Margin | -11,411.11 |
| Pretax Margin | -11,304.83 |
| Profit Margin | -11,304.83 |
| EBITDA Margin | -11,264.73 |
Dividends & Yields
The company's payout ratio of 17.77 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | 17.77 |
| Shareholder Yield | -939.21 |
| FCF Yield | N/A |
Scores
Envoy Medical, Inc. posts an Altman Z-Score of -21.75, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -21.75 |